Thom Lysen

PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands, Netherlands

Poster(s):

• (A-339) 2024 interim results from the VAC4EU post-authorisation safety study (PASS) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) in Europe
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-338) Evaluating the Diagnostic Accuracy of Adverse Events of Special Interest Following Janssen COVID-19 Vaccine (JCOVDEN) Using the VAC4EU Validation Pipeline
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLC-053) Risk of Venous Thrombosis With Thrombocytopenia Syndrome After Vaccination With AZD1222: A European VAC4EU Post-Authorisation Safety Study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET